Supply Chain

Managing donor collections during the COVID-19 pandemic

Cell & Gene Therapy Insights 2020; 6(10), 1397.

10.18609/cgti.2020.152

Published: 4 November 2020
FastFacts
Joy Aho


Watch the video or read the poster to learn:

  • Why COVID-19 has introduced new challenges in collecting and shipping allogeneic donor samples
  • How Be The Match BioTherapies is adapting its processes to keep donors, couriers, and patients safe



About the speaker

Joy Aho PhD, is the Senior Product Manager at Be The Match BioTherapies®, where she develops innovative products and best-in-class services for the cell and gene therapy industry. Prior to joining the team, she worked in product development and management at Bio-Techne for 13 years designing pioneering clinical and discovery tools for the development of cell and gene therapies. Aho received her PhD in Molecular, Cellular, and Developmental Biology & Genetics from the University of Minnesota, and her research led her to studying the role of TGFβ family proteins during embryonic development utilizing stem cells and developmental models. 


   Any Questions?

Ask here!


We hope you enjoyed this FastFacts video. You can also view the summary PDF here.





   Any Questions?

This article is part of the Supply Chain channel
}